Legend Biotech Corporation (FRA:9LB)
Germany · Delayed Price · Currency is EUR 16.50
-3.10 (-15.82%)
Last updated: Jul 28, 2026, 6:00 PM CET
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of €3.28 billion as of July 28, 2026. Its market cap has decreased by -52.91% in one year.
Market Cap
3.28B
Enterprise Value
2.89B
Revenue
987.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
€16.50
ChartMarket Cap Chart
Since June 5, 2020, Legend Biotech's market cap has decreased from 4.23B to 3.28B, a decrease of -22.51%. That is a compound annual growth rate of -4.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 3.78B | 10.39% |
| Dec 31, 2025 | 3.42B | -40.69% |
| Dec 31, 2024 | 5.77B | -41.73% |
| Dec 29, 2023 | 9.90B | 26.55% |
| Dec 30, 2022 | 7.82B | 23.93% |
| Dec 31, 2021 | 6.31B | 106.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 80.40M |
| 2invest AG | 44.52M |
| Biomark Diagnostics | 34.07M |
| Vidac Pharma Holding | 24.63M |
| co.don AG | 427.57K |
| Paion AG | 392.35K |
| bioXXmed AG | 225.65K |